NCT05388006 2026-03-25Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaMayo ClinicPhase 2 Recruiting27 enrolled
NCT05718869 2025-11-04Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL StudyCity of Hope Medical CenterPhase 2 Active not recruiting26 enrolled